Skip to main content
SpringerLink
Log in

Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study was to evaluate the efficacy and safety of early application of citicoline in the treatment of patients with acute stroke by meta-analysis. Randomized controlled trials published until May 2015 were electronically searched in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, WHO International Clinical Trial Registration Platform, Clinical Trial.gov, and China Biology Medicine disc. Two reviewers independently screened the articles and extracted the data based on the inclusion and exclusion criteria. The quality of included articles was evaluated by using Revman5.0, and meta-analysis was performed. The results showed that 1027 articles were obtained in initial retrieval, and finally 7 articles, involving a total of 4039 cases, were included for analysis. The meta-analysis showed that no significant differences were found in the long-term mortality (OR=0.91, 95% CI 0.07 to 1.09, P=0.30), the rate of dependency (OR=1.02, 95% CI 0.87 to 1.24, P=0.85), and the effective rate (OR=0.98, 95% CI 0.84 to 1.14, P=0.82) between citicoline group and control group. The overall rate of adverse events in citicoline group was not significantly different from that in control group (P=0.30). The quality of included articles reached moderate-low level. In conclusion, citicolne cannot reduce long-term mortality and dependence rate in the treatment of acute stroke, and the effective rate of citivoline may be not better than that of controls but with reliable safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. World Health statistics 2008. Geneva, Switzerland. http://www.who.int/whosis/ whostat/ EN_WHS08_Full.pdf

  2. The Atlas of heart disease and stroke, WHO 2004. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf (Mackay J, Mensah G: The Atlas of Heart Disease and Stroke. Geneva, Switzerland, World Health Organization, 2004)

  3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation, 2011,123(4): e18–e209

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sousa RM, Ferri CP, Acosta D, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet, 2009,374(9704):1821–1830

    Article  PubMed  PubMed Central  Google Scholar 

  5. Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003,2(1):43–53

    Article  PubMed  Google Scholar 

  6. Yue J, Xiao Y, Yan Z. Analysis of influence on the hospitalization expenditure of medical insurant patients with stroke. Mod Prev Med 2008;35:71–73

    Google Scholar 

  7. Secades JJ, Frontera G. CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol, 1995,17(Suppl B):1–54

    CAS  PubMed  Google Scholar 

  8. Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke, 1988,19(2):211–216

    Article  CAS  PubMed  Google Scholar 

  9. Sobrino T, Rodriguez-Gonzalez R, Blanco M, et al. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res, 2011,33(6):572–577

    Article  CAS  PubMed  Google Scholar 

  10. Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusionweighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol, 2000,48(5):713–722

    Article  CAS  PubMed  Google Scholar 

  11. Cho HJ, Kim YJ. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases. Methods Find Exp Clin Pharmacol, 2009,31(3): 171–176

    Article  CAS  PubMed  Google Scholar 

  12. Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke, 2002, 33(12):2850–2857

    Article  CAS  PubMed  Google Scholar 

  13. Davalos A, Alvarez-Sabin J, Castillo J, et al. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet, 2012,380(9839):349–357

    Article  CAS  PubMed  Google Scholar 

  14. Chinese Association of Neurosurgery, Chinese Society of Neurosciences. Diagnostic key points of cerebrovascular diseases. Chin J Neurol, 1996,6:60–61

    Google Scholar 

  15. WHO Special Report. Stroke: recommendations on stroke prevention, diagnosis and therapy. Stroke, 1989,20(10): 1407–1431

    Article  Google Scholar 

  16. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions (version 5.1.0). Chichester: John Wiley & Sons, Ltd, 2011:1–28

    Google Scholar 

  17. Higgins JPT, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions (version 5.1.0). Chichester: John Wiley & Sons, Ltd, 2011:1–53

    Google Scholar 

  18. Clark WM, Warach SJ, Pettigrew LC, et al. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology, 1997,49(3):671–678

    CAS  Google Scholar 

  19. Clark WM, Williams BJ, Selzer KA, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke, 1999,30(12):2592–2597

    Article  CAS  PubMed  Google Scholar 

  20. Clark WM, Wechsler LR, Sabounjian LA, et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology, 2001,57(9): 1595–602

    Article  CAS  PubMed  Google Scholar 

  21. Secades JJ, Alvarez-Sabin J, Rubio F, et al. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis, 2006,21(5-6):380–385

    Article  CAS  PubMed  Google Scholar 

  22. Mitta M, Goel D, Bansal KK, et al. Edaravone-citicoline comparative study in acute ischemic stroke (ECCS-AIS). J Assoc Physicians India, 2012,60(hg7, 7505585):36–38

    PubMed  Google Scholar 

  23. Lin WX. The therapeutic effect of edaravone for acute cerebral infarction. Chin J Integ Med Cardio-/Cerebrovasc Dis (Chinese), 2007,5(3):205–207

    Google Scholar 

  24. Tazaki Y, Sakai F, Otomo E, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke, 1988,19(2):211–216

    Article  CAS  PubMed  Google Scholar 

  25. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol, 2006, 28(Suppl B):1–56

    CAS  PubMed  Google Scholar 

  26. Iranmanesh F, Vakilian A. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial. J Stroke Cerebrovasc Dis, 2008,17(3):153–155

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China

    Pei-yu Shi  (石佩玉), Xiao-cui Zhou  (周小翠) & Hong-ying Bai  (白宏英)

  2. Department of Pathology, West China Medical Center of Sichuan University, Chengdu, 610000, China

    Xiao-xue Yin  (尹晓雪)

  3. Department of General Surgery, West China Medical Center of Sichuan University, Chengdu, 610000, China

    Liang-liang Xu  (许亮亮)

  4. Department of Urology, West China Medical Center of Sichuan University, Chengdu, 610000, China

    Xing-ming Zhang  (张兴明)

Authors
  1. Pei-yu Shi  (石佩玉)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-cui Zhou  (周小翠)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao-xue Yin  (尹晓雪)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liang-liang Xu  (许亮亮)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xing-ming Zhang  (张兴明)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong-ying Bai  (白宏英)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong-ying Bai  (白宏英).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shi, Py., Zhou, Xc., Yin, Xx. et al. Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 270–277 (2016). https://doi.org/10.1007/s11596-016-1579-6

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-016-1579-6

Key words

Search

Navigation